$6,957,972,000 for the Food and Drug Administration
What the document says“notwithstanding section 521 of Public Law 107-188; $6,957,972,000: Provided, That of the amount provided under this heading, $1,556,039,000 shall be derived from prescription drug user fees authorized by 21 U.S.C. 379h, and shall be credited to this account and remain available until expended”
The heading funds the agency for fiscal year 2026 and states how much of the total is drawn from each user fee: among others $1,556,039,000 from prescription drug fees, $478,166,000 from medical device fees, $670,900,000 from human generic drug fees and $712,000,000 from tobacco product fees. Within the total, $1,171,319,000 is for the Human Foods Program and $2,496,766,000 for the Center for Drug Evaluation and Research.
What the document actually says“notwithstanding section 521 of Public Law 107-188; $6,957,972,000: Provided, That of the amount provided under this heading, $1,556,039,000 shall be derived from prescription drug user fees authorized by 21 U.S.C. 379h, and shall be credited to this account and remain available until expended”
The food and drug agency gets almost seven billion dollars. A large part of that comes from fees paid by drug makers.
The agency checks drugs, devices, food and tobacco. Companies pay fees when they ask it to review a product. Those fees are part of its budget.
No action is recorded against this proposal. That is not evidence that none has been taken, and nobody has yet read it against the record. See what the tracker does not yet cover.